Copenhagen – November 12, 2026 Predicting how molecules interact is central to drug discovery: it offers important information about how a new drug might work in the human body, the side effects it can cause, and more. Computationally modeling these interactions can reduce the need for lengthy and expensive lab work, but some interactions still remain beyond the reach of classical computers. The Danish quantum software company Kvantify has taken a significant step toward overcoming this challenge by accurately capturing an interaction relevant to biomolecular stability using a novel computational model tested on Quantinuum’s System Model H2 quantum computer. The study focuses on dispersion interactions. These interactions are individually small but collectively make a big difference in helping stabilize, for instance, biological structures such as DNA and proteins, as well as influencing how molecules bind to each other. Accurately describing these interactions is difficult because it involves predicting how electrons behave. Modeling this behavior requires enormous computational resources. Using a pair of molecules derived from a DNA structure, Kvantify investigated how the interaction changes as the molecules move apart. The team applied its quantum algorithm, BEAST-VQE, combined with exact quantum circuit simulation through Qrunch’s optimized integration with NVIDIA cuTensorNet, and compared the results with the established quantum chemistry method CCSD(T). Three key findings: More efficient calculations. Kvantify obtained results matching the accuracy of the CCSD(T) method while reducing the required count of active orbitals from 236 to only 53, thus making the calculation less computationally demanding. Consistency between simulation and hardware. The team ran calculations at two representative molecular geometries on Quantinuum’s System Model H2 quantum computer and produced results almost identical to ideal simulations. This supports the feasibility of studying this subtle interaction on current quantum devices. A step towards practical relevance for drug discovery. The problem of molecular stacking helps test novel computational methods on their way to becoming relevant in real-world quantum chemistry workflows related to molecular recognition and binding. The result is a molecular benchmark, demonstrating how to test the accuracy of computational predictions rather than claiming commercial quantum advantage. The study uses a simplified model, with hardware calculations covering two geometries rather than the full interaction curve. However, it is significant because it shows the value of integrating quantum and classical methods when investigating molecular interactions – even with quantum computers that are available today. The work also highlights the next developmental challenge: reducing classical computational bottlenecks as higher-quality quantum hardware becomes available. About Kvantify Kvantify is a Danish company established in 2022, developing hybrid quantum-classical software for real-world applications, e.g. in life science and drug discovery. The company has 45 employees. Contact David Siebert SVP, Global Head of Business Development ds@kvantify.dk

Raj will lead the global commercial expansion of OrangeQS products and services. He brings two decades of semiconductor experience, with commercial roles at KLA, ASM, Onto Innovation and SMART Photonics.   12 November 2026, Delft, Netherlands – Orange Quantum Systems (OrangeQS) today announces the appointment of Raj Badoni as Chief Commercial Officer (CCO).  The appointment marks an important milestone in the company’s evolution as it strengthens its executive leadership and accelerates its commercial strategy, market development and global growth ambitions with customers and partners. Demand for industrial-scale quantum chip testing is growing.  Raj will focus on expanding FLOW and OrangeQS’s broader portfolio of products and services that enable the transition from quantum chip development to commercial-scale production. From semiconductors to quantum Raj brings 20 years of international experience across the semiconductor and photonics chips industry, having held commercial and leadership roles within leading semiconductor  companies including KLA, ASM, Onto Innovation and SMART Photonics – one of Europe’s leading integrated photonics foundries. Raj is a physicist by training, with master’s degrees from IIT Bombay and the University of North Texas, as well as a graduate certificate in Management Science and Engineering from Stanford University. In an interview, Raj said: “I have spent two decades working in semiconductors and photonics chips industries that have fundamentally shaped the world we live in. What attracted me to OrangeQS was the combination of its technology, its position in the quantum ecosystem and the opportunity to contribute at an important stage in the industry’s development. For me, OrangeQS provides an opportunity to bring my experience in technology, industrialization and commercialization into an industry that is still being shaped, and to help build the commercial foundations for the company’s next phase” “Raj brings extensive experience from the semiconductor and photonics industries and understands what it takes to bring complex technologies closer to industrial and commercial scale,” said Garrelt Alberts, Executive Director at OrangeQS. “That experience will be valuable as we strengthen our customer relationships, strategic partnerships and commercial organization, while continuing to develop our quantum chip testing solutions around the needs of quantum chip developers and manufacturers.” The appointment reinforces OrangeQS’s commitment to accelerating the commercial development of quantum chip testing and measurement and strengthening its position in an emerging technology market with significant long-term potential. Raj can be reached at raj@orangeqs.com. For in-person conversations, He will be in New York next week and at Q2B in Chicago next month. About Orange Quantum Systems Orange Quantum Systems (OrangeQS) is a leading provider of advanced quantum chip test equipment. Headquartered in Delft, the company delivers high-performance systems that enable reliable, scalable, and efficient characterization of qubits and other relevant elements on a quantum chip. With its MAX and FLEX platforms, OrangeQS supports both the global quantum industry and R&D community, while also contributing to open-source innovation through the OrangeQS Juice operating system.   Media contact Amber Van Hauwermeiren, amber@orangeqs.com

Quantum industry leader and former QuIC Executive Director joins SemiQon to accelerate commercialization and strengthen the company’s global market presence. SemiQon, a global leader in scalable quantum hardware and cryo-optimized CMOS solutions, announces the appointment of Dr. Thierry Botter as Chief Commercial Officer (CCO). Dr. Botter brings extensive experience at the intersection of technology, business, and policy, having spent years helping shape the development of the global quantum industry. “Quantum is a unique industry where commercialization is happening in parallel with engineering breakthroughs. We need to build best-in-class technology, but we also need people like Thierry who can bridge the technical with a strong understanding of what the industry needs. Thierry brings a rare combination of ecosystem knowledge, industry connections, and commercial vision that will help SemiQon in this next phase of growth,” says SemiQon CEO Himadri Majumdar. Dr. Botter is widely recognized as a leading voice in the quantum industry. Most recently, he served as Executive Director of the European Quantum Industry Consortium (QuIC), a pan-European association representing more than 230 members and affiliates. He stepped down from the role in August 2026 after a five-year term, during which he helped establish QuIC as one of the key pillars of Europe’s quantum ecosystem. Prior to joining QuIC, Dr. Botter held leadership positions at Airbus, working on advanced technology and innovation initiatives. He holds a PhD in Physics from the University of California, Berkeley, and a master’s degree in aerospace engineering from the University of Illinois Urbana-Champaign. A long-standing contributor to the World Economic Forum’s work on quantum technologies, Dr. Botter has also advised several international industry and policy bodies. “What attracted me to SemiQon is the company’s clear vision for bringing the scalability of semiconductors to quantum computing,” says Dr. Botter. “The team has demonstrated remarkable progress in a short period of time, pairing technological innovation with a strong focus on commercialization. I’m excited to join SemiQon and help accelerate its growth and impact.” Over the past years, SemiQon has achieved major milestones with its cryogenically optimized CMOS technology, secured significant public and private funding, established strategic partnerships, and launched its first commercial products. “Thierry has shown the vision to execute industry-defining projects, both at Airbus and in building QuIC into what it is today,” adds Majumdar. His experience will be invaluable as we continue to shape the future of the quantum industry.”   About SemiQon The future of quantum depends on solving one problem: scalability. SemiQon develops cryo-optimized CMOS solutions that operate at ultra-low temperatures and across qubit modalities. The technology combines unmatched power efficiency at qubit level with the manufacturing advantages of semiconductors. With in-house design, measurement and fabrication facilities, SemiQon is clearing the path for truly scalable quantum computing. www.semiqon.com Media inquiries Ulla Henttonen Head of Public Affairs and Communications ulla.henttonen@semiqon.tech +358 45 7872 0395